Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
argenx
Pharma
Argenx sees early launch success for Vyvgart in CIDP
Vyvgart has reached 300 patients with chronic inflammatory demyelinating polyneuropathy (CIDP) after securing an approval in the disease in late June.
Zoey Becker
Nov 1, 2024 11:46am
Argenx adds 4 new targets to Halozyme collab for $30M
Oct 3, 2024 10:54am
Bayer, Daiichi, argenx leaders on navigating the AI 'hype cycle'
Sep 18, 2024 6:00am
Innovation Honorees
Sep 9, 2024 5:01am
Argenx's Vyvgart holds its own against AZ's rare disease duo
Jul 25, 2024 3:16pm
Argenx lays out bold ambitions for its chief drug Vyvgart
Jul 18, 2024 10:26am
